Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI Clinical Trial
To examine GLP-1 receptors in skin of psoriasis patients compared with the skin of humans with no skin disease
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)